BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17088550)

  • 1. Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters.
    Kohoutek J; Blazek D; Peterlin BM
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17349-54. PubMed ID: 17088550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription-dependent dissociation of P-TEFb-HEXIM1-7SK RNA relies upon formation of hnRNP-7SK RNA complexes.
    Barrandon C; Bonnet F; Nguyen VT; Labas V; Bensaude O
    Mol Cell Biol; 2007 Oct; 27(20):6996-7006. PubMed ID: 17709395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b.
    Shimizu N; Ouchida R; Yoshikawa N; Hisada T; Watanabe H; Okamoto K; Kusuhara M; Handa H; Morimoto C; Tanaka H
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8555-60. PubMed ID: 15941832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic remodelling of human 7SK snRNP controls the nuclear level of active P-TEFb.
    Van Herreweghe E; Egloff S; Goiffon I; Jády BE; Froment C; Monsarrat B; Kiss T
    EMBO J; 2007 Aug; 26(15):3570-80. PubMed ID: 17611602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA depletion of 7SK snRNA induces apoptosis but does not affect expression of the HIV-1 LTR or P-TEFb-dependent cellular genes.
    Haaland RE; Herrmann CH; Rice AP
    J Cell Physiol; 2005 Dec; 205(3):463-70. PubMed ID: 16152622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of polymerase II transcription by 7SK snRNA: two distinct RNA elements direct P-TEFb and HEXIM1 binding.
    Egloff S; Van Herreweghe E; Kiss T
    Mol Cell Biol; 2006 Jan; 26(2):630-42. PubMed ID: 16382153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin T1 but not cyclin T2a is induced by a post-transcriptional mechanism in PAMP-activated monocyte-derived macrophages.
    Liou LY; Haaland RE; Herrmann CH; Rice AP
    J Leukoc Biol; 2006 Feb; 79(2):388-96. PubMed ID: 16330531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.
    Yang Z; Yik JH; Chen R; He N; Jang MK; Ozato K; Zhou Q
    Mol Cell; 2005 Aug; 19(4):535-45. PubMed ID: 16109377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the hinge region of glucocorticoid receptor for HEXIM1-mediated transcriptional repression.
    Yoshikawa N; Shimizu N; Sano M; Ohnuma K; Iwata S; Hosono O; Fukuda K; Morimoto C; Tanaka H
    Biochem Biophys Res Commun; 2008 Jun; 371(1):44-9. PubMed ID: 18407829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein (snRNP) activates hexamethylene bisacetamide-inducible protein (HEXIM1) transcription.
    Liu P; Xiang Y; Fujinaga K; Bartholomeeusen K; Nilson KA; Price DH; Peterlin BM
    J Biol Chem; 2014 Apr; 289(14):9918-25. PubMed ID: 24515107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
    Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
    Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
    Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased HEXIM1 expression during erythroleukemia and neuroblastoma cell differentiation.
    Turano M; Napolitano G; Dulac C; Majello B; Bensaude O; Lania L
    J Cell Physiol; 2006 Mar; 206(3):603-10. PubMed ID: 16222702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
    J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor.
    Michels AA; Fraldi A; Li Q; Adamson TE; Bonnet F; Nguyen VT; Sedore SC; Price JP; Price DH; Lania L; Bensaude O
    EMBO J; 2004 Jul; 23(13):2608-19. PubMed ID: 15201869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
    Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.